Literature DB >> 21821264

Pulse pressure is associated with walking impairment in multiple sclerosis.

Kevin S Heffernan1, Sushant Ranadive, Madeline Weikert, Abbi Lane, Huiman Yan, Bo Fernhall, Robert W Motl.   

Abstract

Persons with multiple sclerosis (MS) have reduced gait performance and this is associated with disability and disease progression. The current study sought to test the hypothesis that higher central (aortic and carotid) and peripheral (brachial) pulse pressure (PP), manifestations of ventricular-vascular uncoupling related to increased arterial stiffness and pressure from wave reflections, would be associated with reduced gait performance in persons with MS. Participants consisted of 33 individuals with MS and 33 age/sex matched controls. Central blood pressure (BP) was assessed via applanation tonometry. Brachial BP was measured using an automated oscillometric cuff. PP was defined as systolic BP--diastolic BP. Gait performance was measured as 6-minute walk (6 MW) distance. Within the sample with MS, the 6 MW distance was significantly associated with brachial (r = -.49, p<.005), aortic (r = -.52, p<.001), and carotid (r = -.57, p<.001) pulse pressure. There was no association between any PP measure and 6 MW distance in controls (p>0.05 for all). In conclusion, PP is a predictor of gait performance in persons with MS. These findings suggest that vascular senescence and altered ventricular-vascular coupling may contribute, in part, to the deterioration of physical function in persons with MS.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21821264     DOI: 10.1016/j.jns.2011.07.004

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  8 in total

1.  Clinically meaningful performance benchmarks in MS: timed 25-foot walk and the real world.

Authors:  Myla D Goldman; Robert W Motl; John Scagnelli; John H Pula; Jacob J Sosnoff; Diego Cadavid
Journal:  Neurology       Date:  2013-10-30       Impact factor: 9.910

2.  Identification and validation of clinically meaningful benchmarks in the 12-item Multiple Sclerosis Walking Scale.

Authors:  Myla D Goldman; Melanie D Ward; Robert W Motl; David E Jones; John H Pula; Diego Cadavid
Journal:  Mult Scler       Date:  2016-12-07       Impact factor: 6.312

3.  Sedentary Behavior and Blood Pressure in Patients with Multiple Sclerosis.

Authors:  Elizabeth A Hubbard; Robert W Motl; Bo Fernhall
Journal:  Int J MS Care       Date:  2018 Jan-Feb

4.  Evidence for the different physiological significance of the 6- and 2-minute walk tests in multiple sclerosis.

Authors:  Robert W Motl; Yoojin Suh; Swathi Balantrapu; Brian M Sandroff; Jacob J Sosnoff; John Pula; Myla D Goldman; Bo Fernhall
Journal:  BMC Neurol       Date:  2012-03-01       Impact factor: 2.474

5.  Prevalence of low ankle brachial index and its association with pulse pressure in an elderly Chinese population: a cross-sectional study.

Authors:  Yiqiang Zhan; Jinming Yu; Ruoqing Chen; Yihong Sun; Yuanyuan Fu; Lijun Zhang; Shechang Li; Fen Zhang; Dayi Hu
Journal:  J Epidemiol       Date:  2012-07-14       Impact factor: 3.211

6.  Relation of pulse pressure to long-distance gait speed in community-dwelling older adults: findings from the LIFE-P study.

Authors:  Kevin S Heffernan; Todd M Manini; Fang-Chi Hsu; Steven N Blair; Barbara J Nicklas; Stephen B Kritchevsky; Anne B Newman; Kim Sutton-Tyrrell; Timothy S Church; William L Haskell; Roger A Fielding
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

7.  A comparison between the pathophysiology of multiple sclerosis and normal pressure hydrocephalus: is pulse wave encephalopathy a component of MS?

Authors:  Grant A Bateman; Jeannette Lechner-Scott; Rodney A Lea
Journal:  Fluids Barriers CNS       Date:  2016-09-22

8.  Blood pressure and body fat percent in women with NMOSD.

Authors:  Xiaohong Chen; Rong Fan; Fuhua Peng; Jia Liu; Jing Huang; Zhigang Chen; Yong Chen; Ying Jiang
Journal:  Brain Behav       Date:  2019-08-03       Impact factor: 2.708

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.